According to BioIntel360, diabetes market in Belgium is expected to grow by 12.1% on annual basis to reach US$1,073.4 million in 2025. The diabetes market in the country has experienced robust growth...
According to BioIntel360, diabetes market in Belgium is expected to grow by 12.1% on annual basis to reach US$1,073.4 million in 2025. The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 13.3%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 10.0% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 957.5 million to approximately USD 1,752.0 million. This report provides a detailed data-centric analysis of the diabetes industry in Belgium, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics. BioIntel360’s research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.
This report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments: Diabetes Devices and Therapeutics Market Share by Category • Diagnosis and Monitoring Devices • Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices • Blood Glucose Monitoring Devices • Insulin Delivery Devices • Diabetes Management and Mobile Applications • Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices • Self-Monitoring Blood Glucose Devices • Continuous Blood Glucose Monitoring Devices • Test Strips • Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices • Insulin Pumps • Insulin Pens • Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics • Oral Anti-Diabetic Drugs • Insulin • Non-Insulin Injectable Drugs • Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs • Alpha-Glucosidase Inhibitors • DPP-4 Inhibitors • SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin • Basal or Long-Acting • Bolus or Fast-Acting • Traditional Human Insulin Drugs • Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs • GLP-1 Receptor Agonists • Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs • Combination Insulin • Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration • Subcutaneous • Intravenous • Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes • Type 1 Diabetes • Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels • Online Pharmacies • Hospital Pharmacies • Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User • Hospitals • Diabetes Clinics • Homecare
• Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user. • Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly. • Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.
1 Belgium Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029 2 Belgium Diabetes Devices and Therapeutics Market Share by Category, 2020-2029 2.1 Belgium Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029 2.2 Belgium Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029 3 Belgium Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029 3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029 3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029 3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029 3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029 4 Belgium Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029 4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029 4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029 4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029 4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029 5 Belgium Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029 5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029 5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029 5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029 6 Belgium Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029 6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029 6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029 6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029 6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029 7 Belgium Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029 7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029 7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029 7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029 8 Belgium Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029 8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029 8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029 8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029 8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029 9 Belgium Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029 9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029 9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029 10 Belgium Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029 10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029 10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029 11 Belgium Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029 11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029 11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029 11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029 12 Belgium Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029 12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029 12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029 13 Belgium Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029 13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029 13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029 13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029 14 Belgium Diabetes Devices and Therapeutics Market Share by End User, 2020-2029 14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029 14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029 14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
Table 1: Belgium Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029 Table 2: Belgium Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029 Table 3: Belgium Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029 Table 4: Belgium Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Table 5: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029 Table 6: Belgium Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029 Table 7: Belgium Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029 Table 8: Belgium Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029 Table 9: Belgium Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Table 10: Belgium Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029 Table 11: Belgium Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029 Table 12: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029 Table 13: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029 Table 14: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029 Table 15: Belgium Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029 Table 16: Belgium Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029 Table 17: Belgium Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029 Table 18: Belgium Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029 Table 19: Belgium Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029 Table 20: Belgium Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029 Table 21: Belgium Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029 Table 22: Belgium Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029 Table 23: Belgium Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029 Table 24: Belgium Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029 Table 25: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029 Table 26: Belgium Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029 Table 27: Belgium Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029 Table 28: Belgium Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029 Table 29: Belgium Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029 Table 30: Belgium Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029 Table 31: Belgium Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029 Table 32: Belgium Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029 Table 33: Belgium Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029 Table 34: Belgium Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029 Table 35: Belgium Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029 Table 36: Belgium Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029 Table 37: Belgium Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029 Table 38: Belgium Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029 Table 39: Belgium Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029 Table 40: Belgium Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
Figure 1: Belgium Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029 Figure 2: Belgium Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029 Figure 3: Belgium Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029 Figure 4: Belgium Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029 Figure 5: Belgium Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029 Figure 6: Belgium Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Figure 7: Belgium Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029 Figure 8: Belgium Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029 Figure 9: Belgium Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029 Figure 10: Belgium Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029 Figure 11: Belgium Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029 Figure 12: Belgium Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Figure 13: Belgium Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029 Figure 14: Belgium Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029 Figure 15: Belgium Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029 Figure 16: Belgium Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029 Figure 17: Belgium Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029 Figure 18: Belgium Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029 Figure 19: Belgium Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029 Figure 20: Belgium Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029 Figure 21: Belgium Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029 Figure 22: Belgium Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029 Figure 23: Belgium Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029 Figure 24: Belgium Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029 Figure 25: Belgium Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029 Figure 26: Belgium Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029 Figure 27: Belgium Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029 Figure 28: Belgium Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029 Figure 29: Belgium Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029 Figure 30: Belgium Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029 Figure 31: Belgium Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029 Figure 32: Belgium Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029 Figure 33: Belgium Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029 Figure 34: Belgium Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029 Figure 35: Belgium Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029 Figure 36: Belgium Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029 Figure 37: Belgium Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029 Figure 38: Belgium Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029 Figure 39: Belgium Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029 Figure 40: Belgium Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029 Figure 41: Belgium Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029 Figure 42: Belgium Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029 Figure 43: Belgium Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029 Figure 44: Belgium Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029 Figure 45: Belgium Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029 Figure 46: Belgium Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029 Figure 47: Belgium Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029 Figure 48: Belgium Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029 Figure 49: Belgium Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029 Figure 50: Belgium Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029 Figure 51: Belgium Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029 Figure 52: Belgium Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029 Figure 53: Belgium Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
